Quark and pion condensation in a chromomagnetic background field

The general features of quark and pion condensation in dense quark matter with flavor asymmetry have been considered at finite temperature in the presence of a chromomagnetic background field modelling the gluon condensate. In particular, pion condensation in the case of a constant abelian chromomagnetic field and zero temperature has been studied both analytically and numerically. Under the influence of the chromomagnetic background field the effective potential of the system is found to have a global minimum for a finite pion condensate even for small values of the effective quark coupling constant. In the strong field limit, an effective dimensional reduction has been found to take place.Comment: 17 pages, 6 figure

Inverse magnetic catalysis in field theory and gauge-gravity duality

We investigate the surface of the chiral phase transition in the three-dimensional parameter space of temperature, baryon chemical potential and magnetic field in two different approaches, the field-theoretical Nambu-Jona-Lasinio (NJL) model and the holographic Sakai-Sugimoto model. The latter is a top-down approach to a gravity dual of QCD with an asymptotically large number of colors and becomes, in a certain limit, dual to an NJL-like model. Our main observation is that, at nonzero chemical potential, a magnetic field can restore chiral symmetry, in apparent contrast to the phenomenon of magnetic catalysis. This "inverse magnetic catalysis" occurs in the Sakai-Sugimoto model and, for sufficiently large coupling, in the NJL model and is related to the physics of the lowest Landau level. While in most parts our discussion is a pedagogical review of previously published results, we include new analytical results for the NJL approach and a thorough comparison of inverse magnetic catalysis in the two approaches.Comment: 37 pages, 11 figures, to appear in Lect. Notes Phys. "Strongly interacting matter in magnetic fields" (Springer), edited by D. Kharzeev, K. Landsteiner, A. Schmitt, H.-U. Ye

Quark Matter in a Strong Magnetic Background

In this chapter, we discuss several aspects of the theory of strong interactions in presence of a strong magnetic background. In particular, we summarize our results on the effect of the magnetic background on chiral symmetry restoration and deconfinement at finite temperature. Moreover, we compute the magnetic susceptibility of the chiral condensate and the quark polarization at zero temperature. Our theoretical framework is given by chiral models: the Nambu-Jona-Lasinio (NJL), the Polyakov improved NJL (or PNJL) and the Quark-Meson (QM) models. We also compare our results with the ones obtained by other groups.Comment: 34 pages, survey. To appear in Lect. Notes Phys. "Strongly interacting matter in magnetic fields" (Springer), edited by D. Kharzeev, K. Landsteiner, A. Schmitt, H.-U. Ye

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

23rd IAEA Fusion Energy Conference: summary of sessions EX/C and ICC

An overview is given of recent experimental results in the areas of innovative confinement concepts, operational scenarios and confinement experiments as presented at the 2010 IAEA Fusion Energy Conference. Important new findings are presented from fusion devices worldwide, with a strong focus towards the scientific and technical issues associated with ITER and W7-X devices, presently under construction